POST TRANSPLANT ERYTHROCYTOSIS AND THE EFFECT OF TREATMENT WITH ENALAPRIL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MIR JALALI MOHAMMAD REZA; RAHIMIAN M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Kerman University of Medical Sciences Year:2008 | Volume:15 | Issue:1 Page(s): 1-7

Download Full-Text

Persian Verion

View:

1,148

Download:

Cites:

Information Journal Paper

Title

POST TRANSPLANT ERYTHROCYTOSIS AND THE EFFECT OF TREATMENT WITH ENALAPRIL

Author(s)

MIR JALALI MOHAMMAD REZA | RAHIMIAN M. | Issue Writer Certificate

Keywords

POST TRANSPLANT ERYTHROCYTOSISQ3

RENAL TRANSPLANTATIONQ2

ENALAPRILQ2

Abstract

Introduction: POST TRANSPLANT ERYTHROCYTOSIS (PTE), defined as a hematocrit level of above 51 percent, is a multifactorial condition common in renal transplant recipients. Traditional therapies include repeated phlebotomies, bilateral native nephrectomies, and anticoagulant therapy. The aim of this study was to evaluate the efficacy of ACE inhibitor on PTE.Methods: This analytic outcome study was done on all transplant patients referred to Shaid Rahnemoon hospital (Yazd, Iran). Hematocrit (HCn and hemoglobin were assessed in two blood samples taking from the patients. Patients with HCT >51 were selected and studied for other causes of polycythemia. Not fmding other causes, the patients were diagnosed as PTE and received ENALAPRIL tab (5 mg /daily). Blood pressure, HCT and Hb of these patients were recorded during next 3 months (30, 60, 90th post-treatment days).Results: Among 126 referred patients, 47 patients had erythrocytosis [37 males (86%) and 6 females (14%)] that shows a higher prevalence in comparison with other studies. All patients responded to ENALAPRIL treatment Before treatment, mean hemoglobin and hematocrit were 18.35±0.59 gr/l and 55.96±1.90mm respectively, while after 3 months treatment with ENALAPRIL, hemoglobin and hematocrit decreased to 16.7±0.5 mgl/and 48.73±1.42mm respectively.Conclusion: ENALAPRIL is an effective treatment of PTE and can prevent the need for phlebotomy or nephrectomy in these patients.

Cites

No record.

References

No record.

Cite

APA: Copy

MIR JALALI, MOHAMMAD REZA, & RAHIMIAN, M.. (2008). POST TRANSPLANT ERYTHROCYTOSIS AND THE EFFECT OF TREATMENT WITH ENALAPRIL. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, 15(1), 1-7. SID. https://sid.ir/paper/484/en

Vancouver: Copy

MIR JALALI MOHAMMAD REZA, RAHIMIAN M.. POST TRANSPLANT ERYTHROCYTOSIS AND THE EFFECT OF TREATMENT WITH ENALAPRIL. JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2008;15(1):1-7. Available from: https://sid.ir/paper/484/en

IEEE: Copy

MOHAMMAD REZA MIR JALALI, and M. RAHIMIAN, “POST TRANSPLANT ERYTHROCYTOSIS AND THE EFFECT OF TREATMENT WITH ENALAPRIL,” JOURNAL OF KERMAN UNIVERSITY OF MEDICAL SCIENCES, vol. 15, no. 1, pp. 1–7, 2008, [Online]. Available: https://sid.ir/paper/484/en

Related Journal Papers